Stem cell transplantation (PBSCT) for chronic myelogenous leukemia (CML).

被引：0
|
作者：
Massumoto, C
Hamerschlack, N
Ferreira, E
Pietrocola, M
Katz, F
Kutner, JM
Alves, A
机构：
[1] Hosp Sirio Libanes, Ctr Oncol, Sao Paulo, Brazil
[2] Hosp Israelita Albert Einstein, Sao Paulo, Brazil
[3] Ctr Hemoterapia Sao Lucas, Sao Paulo, Brazil
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4781
引用
收藏
页码：262B / 262B
页数：1
相关论文
共 50 条
  • [1] TIMING OF MARROW TRANSPLANTATION IN CHRONIC MYELOGENOUS LEUKEMIA (CML)
    SEGEL, GB
    LICHTMAN, MA
    SIMON, W
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 220 - 220
  • [2] ALLOGENEIC MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA (CML)
    BUCKNER, CD
    CLIFT, RA
    STORB, R
    THOMAS, ED
    EXPERIMENTAL HEMATOLOGY, 1986, 14 (06) : 486 - 486
  • [3] Generation of an embryonic stem (ES) cell model of chronic myelogenous leukemia (CML).
    Turhan, AG
    Bonnet, ML
    Le Pesteur, D
    Mitjavila, M
    Vainchenker, W
    Sainteny, F
    BLOOD, 1999, 94 (10) : 101A - 101A
  • [4] AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
    GOLDMAN, JM
    SEMINARS IN HEMATOLOGY, 1993, 30 (03) : 53 - 54
  • [5] TRANSPLANTATION REGIMENS FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) IN CHRONIC PHASE (CP)
    CLIFT, RA
    BUCKNER, CD
    STORB, R
    THOMAS, ED
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 501 - 501
  • [6] Favourable survival of allogeneic stem cell transplantation after prior cytogenetic response to IFN in chronic myelogenous leukemia (CML).
    Reiter, A
    Maywald, O
    Metzgeroth, G
    Berger, U
    Hochhaus, A
    Pfirrmann, M
    Gnad, SU
    Kolb, HJ
    Gratwohl, A
    Bunjes, D
    Schaefer, UW
    Zander, AR
    Finke, J
    Arnold, R
    Fauser, AA
    Schwerdtfeger, R
    Sahakyan, L
    Hasford, J
    Hehlmann, R
    BLOOD, 2002, 100 (11) : 323B - 323B
  • [7] Impact of imatinib therapy on the use of allogeneic hematopoietic stem cell transplantation (HSCT) for treatment of the chronic myelogenous leukemia (CML).
    Giralt, S
    Sobocinski, K
    Horowitz, MM
    BLOOD, 2003, 102 (11) : 473A - 473A
  • [8] Imatinib (Glivec) therapy in advanced chronic myeloid leukemia (CML) patients in combination with allogeneic peripheral blood stem cell transplantation (PBSCT).
    le Coutre, P
    Massenkeil, G
    Zschieschang, P
    Genvresse, I
    Schwarz, M
    Reich, G
    Körner, H
    Dörken, B
    Arnold, R
    BLOOD, 2002, 100 (11) : 428A - 429A
  • [9] Peripheral blood stem cell transplantation (PBSCT) during consolidation treatment of de novo acute myelogenous leukemia
    Reichle, A
    Hennemann, B
    Meidenbauer, N
    Zaiss, M
    Bross, KJ
    Andreesen, R
    BLOOD, 1996, 88 (10) : 3874 - 3874
  • [10] Safety and efficacy of STI-571 (imatinib mesylate) in patients with bcr/abl-positive chronic myelogenous leukemia (CML) after autologous peripheral blood stem cell transplantation (PBSCT)
    T Fischer
    C Reifenrath
    GR Hess
    MT Corsetti
    S Kreil
    J Beck
    P Meinhardt
    G Beltrami
    B Schuch
    H Gschaidmeier
    R Hehlmann
    A Hochhaus
    A Carella
    C Huber
    Leukemia, 2002, 16 : 1220 - 1228
12345